Galderma Group Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,923,175 | 1.23% |
General Public | 13,533,018 | 5.7% |
Private Companies | 21,098,311 | 8.88% |
Hedge Funds | 24,722,328 | 10.4% |
Institutions | 37,429,726 | 15.8% |
VC/PE Firms | 137,859,870 | 58% |
Dilution of Shares: GALD only recently listed within the past 12 months
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
112,073,420 | CHF 12.4b | -13.3% | 72.8% | |||
25,786,450 | CHF 2.9b | 0% | 43.53% | |||
24,722,328 | CHF 2.7b | 0% | 20.92% | |||
21,098,311 | CHF 2.3b | 435% | no data | |||
4,981,781 | CHF 551.5m | 10.6% | 0.06% | |||
4,327,815 | CHF 479.1m | 14% | 0.08% | |||
3,707,724 | CHF 410.4m | 7.48% | 0.03% | |||
3,256,371 | CHF 360.5m | 38% | 0.01% | |||
2,879,570 | CHF 318.8m | 29% | 0.01% | |||
1,732,782 | CHF 191.8m | 10% | 0.4% | |||
1,639,781 | CHF 181.5m | 0% | no data | |||
1,374,035 | CHF 152.1m | 8.84% | 0.15% | |||
1,329,522 | CHF 147.2m | 0% | 2.46% | |||
1,012,764 | CHF 112.1m | 81.5% | 0.25% | |||
970,949 | CHF 107.5m | 1.79% | 0.04% | |||
859,679 | CHF 95.2m | 0% | 0.03% | |||
805,410 | CHF 89.2m | -9% | 0.04% | |||
726,546 | CHF 80.4m | 27,300% | 0.05% | |||
644,427 | CHF 71.3m | 0% | 0.28% | |||
594,358 | CHF 65.8m | 0% | no data | |||
576,786 | CHF 63.9m | -3.8% | 0.05% | |||
552,365 | CHF 61.1m | 0% | no data | |||
534,132 | CHF 59.1m | 43.1% | no data | |||
500,000 | CHF 55.4m | 0% | no data | |||
497,943 | CHF 55.1m | 63.7% | 0.05% |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/01 05:59 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Galderma Group AG is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Bethan Davies | Berenberg |
Richard Parkes | BNP Paribas Exane |
Joffrey Meller | BofA Global Research |